Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase IV Multicentric Clinical Trial to Evaluate the Efficacy of Hyperthermic Intraperitoneal Chemotherapy (HIPEC) With Mytomicin-C After Complete Surgical Cytoreduction in Patients With Colon Cancer Peritoneal Metastases

NCT05250648 is registered in ClinicalTrials.gov with Hospital Universitario de Fuenlabrada as lead sponsor.

NCT NCT05250648
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05250648 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase IV Multicentric Clinical Trial to Evaluate the Efficacy of Hyperthermic Intraperitoneal Chemotherapy (HIPEC) With Mytomicin-C After Complete Surgical Cytoreduction in Patients With Colon Cancer Peritoneal Metastases
Lead sponsor
Hospital Universitario de Fuenlabrada
Phase
Phase 4
Overall status
Recruiting
Start date
March 2, 2022
Completion date
October 31, 2029
Enrollment
216 (estimated)
Sites
31

Conditions

As the registry lists them; a condition with its own page is linked.

colon cancer, peritoneal carcinomatosis